Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme -- Ignore unavailable to you. Want to Upgrade?

To: Leman who wrote (3563)	6/9/1998 12:32:00 PM
From: AKAPAK	Respond to of 8798

Anybody remember BCAM? Qtrly results out...Looks like good revenues and gross profits for LT but this qtr stuffed with dead weight discarded...... MELVILLE, N.Y., June 9 /PRNewswire/ -- BCAM International, Inc. (Nasdaq: BCAM; Boston Stock Exchange: BAM), announced its results for the first quarter ended March 31, 1998. Revenues from continuing operations totaled $3,837,000 for the quarter. Revenues for the first quarter of 1998 reflect principally the revenues of the Company's Drew Shoe Corporation subsidiary. Drew Shoe's results of operations have been included in the Company's results since its acquisition during September 1997. As a result, Drew Shoe's revenues and operations are not included in the Company's quarterly results for the prior year. Drew Shoe's first quarter revenues were approximately 3.5% higher in 1998 than the prior year. During the first quarter of 1998 operations of the Ergonomic Consulting Services business ("ECS") were sold and the HumanCAD Systems business ("HCAD") was discontinued. Both ECS and HCAD have been reflected as discontinued operation. Net loss of $4,183,000 for the quarter ended March 31, 1998 reflects non- cash charges for the beneficial conversion feature of certain issued securities which are convertible into the common stock of the Company ($1,493,000), non-cash charges for compensation related to certain options which were at market value when issued in 1997 but below the market value when approved by the shareholders on February 19, 1998 ($858,000), and losses from discontinued operations ($803,000). See enclosed table for financial comparison to the prior year first quarter. "The financial results reflect the steps the Company has taken to identify noncontributing businesses, prioritize its investment spending and position itself for significant growth through acquisitions," said Michael Strauss, Chairman and Chief Executive Officer of BCAM. "With the discontinued operations now behind us, we can focus on the two key elements of our strategy; acquisitions in the medical footcare and related businesses and building our core IST and Microvalve technology. The recent $2,000,000 private placement and the restructuring of the Convertible Notes supports our strategy. Further, additional products incorporating our IST technology will be introduced in the second half of 1998. I am very excited and confident about our future growth potential." BCAM International Inc., Melville, New York, specializes in the development of technology that enables surfaces to adjust themselves in real time to conform to any part of the body for utmost of comfort, fit and enhanced user performance, and also in the consolidation of the highly fragmented medical footcare industry. FORWARD LOOKING STATEMENTS This announcement contains "forward-looking" statements. The words, "anticipate," "believe," "estimate," and "expect" and other similar expressions as they relate to the Company and its management are intended to identify such forward-looking statements. Although the Company and its management believe that the statements contained in this announcement are reasonable, it can give no assurances that such statements will prove correct. Factors that could affect the occurrence of events or results discussed herein include those mentioned in the Company's Form 10-KSB.